Literature DB >> 21787764

Assessment of clinical performance without adequate analytical validation: A prescription for confusion.

Lawrence K Oliver1, Nikolay Voskoboev, Don Heser, Joseph P McConnell, Shannon Hodel-Hanson, Heidi Callanan, Allan S Jaffe.   

Abstract

OBJECTIVES: Lp-PLA2 is a biomarker with promise for predicting cardiac risk. The lack of reproducible results has limited its use. In evaluating a new reagent kit, we investigated conditions for optimal reproducibility.
METHODS: The Auto-PLAC reagents were evaluated on the Cobas instrument. Performance characteristics, stability, and population ranges were determined.
RESULTS: Analytical performance characteristics replicated manufacturer's claims. The stability profile of the analyte was unusual, with increasing results observed with storage at 4°C or -20°C. Only storage at -70°C gave acceptable stability. Population median values with properly preserved samples were much lower than the cut off previously validated for increased risk.
CONCLUSIONS: It is postulated that variability in specimen handling was a major contributor to the lack of traceability of the current reagents to the earlier clinical studies demonstrating its utility. We are now unsure how to identify reliable criteria for result interpretation.
Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21787764     DOI: 10.1016/j.clinbiochem.2011.07.005

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  4 in total

Review 1.  Biomarker tests for risk assessment in coronary artery disease: will they change clinical practice?

Authors:  Johannes Mair; Allan S Jaffe
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

2.  Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: the Northern Manhattan Study.

Authors:  Mira Katan; Yeseon P Moon; Myunghee C Paik; Robert L Wolfert; Ralph L Sacco; Mitchell S V Elkind
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

Review 3.  Can lipoprotein-associated phospholipase A2 be used as a predictor of long-term outcome in patients with acute coronary syndrome?

Authors:  Sine Holst-Albrechtsen; Maria Kjaergaard; Anh-Nhi Thi Huynh; Johanne Kragh Sorensen; Susanne Hosbond; Mads Nybo
Journal:  Curr Cardiol Rev       Date:  2013-11

4.  Association of lipoprotein-associated phospholipase A2 mass with asymptomatic cerebral artery stenosis.

Authors:  Youxin Wang; Bin Zhou; Pingan Zhou; Yan Yao; Qinghua Cui; Yingping Liu; Jichun Yang; Shouling Wu; Xingquan Zhao; Yong Zhou
Journal:  J Cell Mol Med       Date:  2018-02-09       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.